Description:

Phase II Study to evaluate the response on two blocks of topotecan and carboplatin

Keywords:
Versions (1) ▾
  1. 12/9/13
Uploaded on:

December 9, 2013

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00130858 # Soft Tissue Sarcoma

Details

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion criteria
Both
age < 21
Soft tissue sarcoma chemosensible, stage IV
measurable tumor lesions
Exclusion criteria
Lack of cooperation by the patient
no willingness of follow-up examinations
participation on another clinical trial at the same time
death due to the sickness within four weeks
Medical Concepts
Back to the top of the page